We had previously connected low CD8 expression by cytotoxic T cells to the induction of the membrane‐bound receptor for IL‐33, suppression of tumourigenicity 2 (ST2)L14, 15; we included this receptor and IL6ST (CD130) as two promising factors for the validation of CD8Low T cells in tumour sections. The gene discussed is IL33; the disease is neoplasm.